Celgene fights for sanction on patent challenger Bass

Posted: July 30th, 2015  |  Company/topic: Celgene
Celgene is hedge fund manager Kyle Bass' latest patent target, it says--but the biotech isn't taking the news lying down.

Celgene says patent-fighting hedge fund manager wants to short its shares

Posted: July 29th, 2015  |  Company/topic: Celgene
NEW YORK, July 29 (Reuters) - Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out seve…

Celgene May Also Want to Take Notice of PharmaCyte Biotech

Posted: July 24th, 2015  |  Company/topic: Celgene
BONITA, CA--(Marketwired - July 24, 2015) - A recent deal between Celgene and Juno Therapeutics is just a microcosm of the mindset that may ultimately drive a similar deal between it -- or a competito…

East Coast Biotech Roundup: Celgene, Chiasma, Cerulean, & More

Posted: July 17th, 2015  |  Company/topic: Celgene
[Updated 7/19/15, 9:36 p.m. See below.] In this week’s Celgene roundup—sorry, this week’s biotech roundup—Celgene is yet again leading the way with its second billion-plus…